Credit: Scott Bodell/MedicalImages.com The authors outline preventative pharmacologic therapies for COPD exacerbations and a patient-tailored approach to management. Chronic obstructive pulmonary ...
In patients with chronic obstructive pulmonary disease (COPD), increasing frequency and severity of exacerbations were linked to a higher risk of future exacerbations and all-cause and COPD-related ...
Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
Most chronic obstructive pulmonary disease (COPD) exacerbations were observed in those not treated with controller medications, but less than half of patients in the study received controller ...
New research shows that individual exacerbations in chronic obstructive lung disease (COPD) themselves increase the likelihood of repeat exacerbations, even after five days of full, asymptomatic ...
bronchodilators, COPD Triple therapy with budesonide/glycopyrrolate/formoterol fumarate in patients with COPD, regardless of exacerbation history, reduced ...
Woman suffering an anxiety attack alone in the night How does a delay in initiating triple therapy affect patients with COPD with a history of several moderate COPD exacerbations during a 1-year ...
Please provide your email address to receive an email when new articles are posted on . Minimum pitch in the morning was significantly higher at exacerbation onset and peak vs. baseline. In the ...
Findings suggest that patients with COPD should be closely monitored for the risk of acute cardiovascular (CV) events following COPD exacerbations, and prevention of exacerbations should be a major ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. COPD exacerbations went down by 51% in patients with ...
Paris and Tarrytown, N.Y. November 27, 2023. The second Dupixent® (dupilumab) investigational Phase 3 chronic obstructive pulmonary disease (COPD) trial (NOTUS) has shown that Dupixent significantly ...
MedPage Today on MSN
Novel Biologic Gets Narrow Win for Preventing COPD Flare-ups
The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback